计算机辅助设计FAPα酶激活式鬼臼毒素抗肿瘤前体药物分子
Virtual Design of FAPα-Activated Anti-Tumor Prodrug of Podophyllotoxin
DOI: 10.12677/HJMCe.2021.92004, PDF,    科研立项经费支持
作者: 梁光平：遵义医药高等专科学校，贵州 遵义；贵州省野生药用植物资源持续利用协同创新中心，贵州 遵义；黄远梅, 黄启章, 杨 俊*：遵义医药高等专科学校，贵州 遵义
关键词: FAPα酶；鬼臼毒素；抗肿瘤；计算机辅助药物设计；FAPα； Podophyllotoxin； Anti-Tumor； Computer Assisted Drug Design
摘要: 为了获得成纤维细胞激活蛋白α (Fibroblast Activation Protein，简称FAPα酶)激活式鬼臼毒素抗肿瘤前体药物分子，利用AutoDock tools、PyMOL和Ligplot软件模块的功能，设计FAPα酶的特异性底物N-苄氧羰基甘氨酰-L-脯氨酸与鬼臼毒素4-OH偶联中间片段及最终化合物的结构。通过虚拟设计共获得31个Affinity(kcal/mol)评分值小于−9.5分的化合物，并阐明了5个最优代表的复合物模拟三维结构与分子互作机制，为FAPα酶激活式鬼臼毒素抗肿瘤药物研发提供潜在的先导化合物，以指导后期研究的进一步开展。
Abstract: To obtain the anti-tumor prodrugs of FAPα-activated podophyllotoxin, the intermediate structure of N-benzyloxycarbonylglycine-L-proline coupling with podophyllotoxin was designed by using Auto-Dock tools, PyMOL and Ligplot software modules. A total of 31 compounds with affinity scores less than −9.5 kcal/mol were obtained by virtual design, and the three-dimensional structure and mo-lecular interaction mechanism of five optimal representative complexes were clarified, which pro-vided potential lead compounds for the research and development of FAPα-activated anti-tumor prodrug of podophyllotoxin to guide the further research.
文章引用：梁光平, 黄远梅, 黄启章, 杨俊. 计算机辅助设计FAPα酶激活式鬼臼毒素抗肿瘤前体药物分子[J]. 药物化学, 2021, 9(2): 28-34. https://doi.org/10.12677/HJMCe.2021.92004

参考文献

[1] Ariga, N., Sato, E., Ohuchi, N., et al. (2001) Stromal Expression of Fibroblast Activation Protein/Seprase, a Cell Mem-brane Serine Proteinase and Gelatinase, Is Associated with Longer Survival in Patients with Invasive Ductal Carcinoma of Breast. International Journal of Cancer, 95, 67-72. [Google Scholar] [CrossRef] 
[2] Monsky, W., Lin, C., Aoyama, A., et al. (1994) A Potential Marker Protease of Invasiveness, Separase, Is Localized on Invadopodia of Human Malignant Melanoma Cells. Cancer Research, 54, 5702-5710.
[3] Ghersi, G., Dong, H., Goldstein, L.A., et al. (2002) Regulation of Fibroblast Migration on Collagenous Matrix by a Cell Surface Peptidase Complex. Journal of Biological Chemistry, 277, 29231-29241. [Google Scholar] [CrossRef] 
[4] Garin-Chesa, P., Old, L.J. and Rettig, W.J. (1990) Cell Surface Glycoprotein of Reactive Stromal Fibroblasts as a Potential Antibody Target in Human Epithelial Cancers. Proceedings of the National Academy of Sciences, 87, 7235-7239. [Google Scholar] [CrossRef] [PubMed]
[5] Khaled, M., Jiang, Z. and Zhang, L. (2013) Deoxypodophyllotoxin: A Promising Therapeutic Agent from Herbal Medicine. Journal of Ethnopharmacology, 149, 24-34. [Google Scholar] [CrossRef] [PubMed]
[6] Arpicco, S., Dosio, F., Stella, B., et al. (2011) Anticancer Prodrugs: An Overview of Major Strategies and Recent Developments. Current Topics in Medicinal Chemistry, 11, 2346-2381. [Google Scholar] [CrossRef] [PubMed]
[7] Bailly, C. (2012) Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy. Chemical Reviews, 112, 3611-3640. [Google Scholar] [CrossRef] [PubMed]
[8] Singh, P.K., Kumar, R., Sharma, A., et al. (2009) Podophyllum Hexandrum Fraction (REC-2006) Shows Higher Radioprotective Efficacy in the p53-Carrying Hepatoma Cell Line: A Role of Cell Cycle Regulatory Proteins. Integrative Cancer Therapies, 8, 261-272. [Google Scholar] [CrossRef] [PubMed]
[9] 张尔贤, 俞丽君, 沈立光. 具抗癌活性的鬼桕毒电子自旋标记物的生物学作用研究II.对环腺苷酸磷酸二酯酶的影响[J]. 中国生化药物杂志, 1993(3): 27-31.
[10] Xu, H., Lv, M. and Tian, X. (2009) A Review on Hemisynthesis, Biosynthesis, Biological Activities, Mode of Action, and Struc-ture-Activity Relationship of Podophyllotoxins: 2003-2007. Current Medicinal Chemistry, 16, 327-349. [Google Scholar] [CrossRef] [PubMed]
[11] Zhao, L., Ciallella, H., Aleksunes, L., et al. (2020) Advancing Computer-Aided Drug Discovery (CADD) by Big Data and Data-Driven Machine Learning Modeling. Drug Discovery Today, 25, 1624-1638. [Google Scholar] [CrossRef] [PubMed]
[12] 庄莉, 翟园园, 姚卫峰, 等. 基于网络药理学的二至丸对肾脏保护作用的机制研究[J]. 药学学报, 2019, 54(5): 877-885.
[13] 刘福和, 陈少军, 倪文娟. 川芎中抗血栓活性成分的计算机虚拟筛选研究[J]. 中国药房, 2017(16): 2182-2186.
[14] 姬勋. 基于DPP4和EGFR靶点的药物设计、合成及相关药理活性研究[D]: [博士学位论文]. 沈阳: 沈阳药科大学, 2014.
[15] 韩小艳. Linker长度对MDC和CVB3VP1融合基因疫苗免疫效果的影响[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2007.